Licensing Opportunity: Broadly Protective Influenza Vaccine

Broadly Protective Influenza Vaccine

Licensing Opportunity

3D print of influenza virus. The virus surface (yellow) is covered with proteins called hemagglutinin (blue) and neuraminidase (red) that enable the virus to enter and infect human cells. Credit: NIH

According to the Centers for Disease Control and Prevention (CDC), it is estimated that there have been at least 4.6 million influenza illnesses in the 2019 – 2020 season. There is a great need for a broadly protective, universal flu vaccine. NIAID researchers have composed a cocktail of at least four different low pathogenicity avian influenza virus subtypes inactivated by betapropiolactone (BPL). This universal flu vaccine candidate has potential to offer broad protection against both seasonal and pandemic-potential flu viruses. Read more about this exciting licensing opportunity at Read more about this exciting licensing opportunity at www.ott.nih.gov/technology/e-033-2018 or contact Jenish Patel, Ph.D., 240-669-2894; jenish.patel@nih.gov.